Arthrex Inc., according to a press release issued by the company, has granted FDA clearance for its TightRope Implant for use in pediatric patients suffering from ACL injuries.
“For more than a decade, Arthrex has worked closely with leading orthopedic surgeons from Hospital for Special Surgery (HSS) to develop minimally invasive solutions for pediatric and young adolescent ACL surgery,” Reinhold Schmieding, president and founder of Arthrex, said in the release. “We are proud to partner with surgeons from HSS to design treatment options specifically for ACL injuries in younger patients. This is a
